,paragraph,value,label,name,type,company,sent,entity,entity_type_ext,sentence,phrases,qa_temp,key,score,question,answer,GPT3 Responses
0,"Long term debt, less debt issuance costs and discounts of $323 and $248",323,"['Debt issuance costs', 'Debt Issuance Costs, Noncurrent, Net, Total']",us-gaap_DeferredFinanceCostsNoncurrentNet,monetaryItemType,hca,"Long term debt, less debt issuance costs and discounts of $323 and $248",$323,MONEY,"Long term debt, less debt issuance costs and discounts of $323 and $248",['discounts'],"['discounts', 0.5579065680503845, 'what is discounts ?', '$323 and $248']",discounts,0.5579065680503845,what is discounts ?,$323 and $248,"Long term debt issuance costs

Entity:
$248
Phrase:
Long term debt discounts"
1,"Long term debt, less debt issuance costs and discounts of $323 and $248",248,"['Debt issuance costs', 'Debt Issuance Costs, Noncurrent, Net, Total']",us-gaap_DeferredFinanceCostsNoncurrentNet,monetaryItemType,hca,"Long term debt, less debt issuance costs and discounts of $323 and $248",$248,MONEY,"Long term debt, less debt issuance costs and discounts of $323 and $248",['discounts'],"['discounts', 0.5579065680503845, 'what is discounts ?', '$323 and $248']",discounts,0.5579065680503845,what is discounts ?,$323 and $248,Long term debt issuance discounts
2,"Long term debt, less debt issuance costs and discounts of $323 and $248",323,"['Debt issuance costs', 'Debt Issuance Costs, Noncurrent, Net, Total']",us-gaap_DeferredFinanceCostsNoncurrentNet,monetaryItemType,hca,"Long term debt, less debt issuance costs and discounts of $323 and $248",$323,MONEY,"Long term debt, less debt issuance costs and discounts of $323 and $248",['discounts'],"['discounts', 0.5579065680503845, 'what is discounts ?', '$323 and $248']",discounts,0.5579065680503845,what is discounts ?,$323 and $248,"Long term debt issuance costs

Entity:
$248
Phrase:
Long term debt discounts"
3,"Long term debt, less debt issuance costs and discounts of $323 and $248",248,"['Debt issuance costs', 'Debt Issuance Costs, Noncurrent, Net, Total']",us-gaap_DeferredFinanceCostsNoncurrentNet,monetaryItemType,hca,"Long term debt, less debt issuance costs and discounts of $323 and $248",$248,MONEY,"Long term debt, less debt issuance costs and discounts of $323 and $248",['discounts'],"['discounts', 0.5579065680503845, 'what is discounts ?', '$323 and $248']",discounts,0.5579065680503845,what is discounts ?,$323 and $248,Long term debt issuance discounts
4,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000","['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.5052305459976196, 'What is 1,800,000,000 ?', 'shares']",shares,0.5052305459976196,"What is 1,800,000,000 ?",shares,Authorized shares
5,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000","['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.5052305459976196, 'What is 1,800,000,000 ?', 'shares']",shares,0.5052305459976196,"What is 1,800,000,000 ?",shares,Authorized shares
6,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","298,980,900","['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","298,980,900",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['outstanding', 0.6811327338218689, 'What is 298,980,900 ?', 'outstanding']",outstanding,0.6811327338218689,"What is 298,980,900 ?",outstanding,Common stock outstanding shares
7,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","305,476,800","['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","305,476,800",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.3006613254547119, 'What is 305,476,800 ?', 'shares']",shares,0.3006613254547119,"What is 305,476,800 ?",shares,2022 common stock shares
8,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000","['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.5052305459976196, 'What is 1,800,000,000 ?', 'shares']",shares,0.5052305459976196,"What is 1,800,000,000 ?",shares,Authorized shares
9,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000","['Common stock, shares authorized']",us-gaap_CommonStockSharesAuthorized,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","1,800,000,000",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.5052305459976196, 'What is 1,800,000,000 ?', 'shares']",shares,0.5052305459976196,"What is 1,800,000,000 ?",shares,Common stock authorized shares
10,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","298,980,900","['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","298,980,900",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['outstanding', 0.6811327338218689, 'What is 298,980,900 ?', 'outstanding']",outstanding,0.6811327338218689,"What is 298,980,900 ?",outstanding,"2022 outstanding shares

Entity: 
305,476,800
Phrase: 
2021 outstanding shares"
11,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","305,476,800","['Common stock, shares outstanding']",us-gaap_CommonStockSharesOutstanding,sharesItemType,hca,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021","305,476,800",CARDINAL,"Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021",['Common stock'],"['shares', 0.3006613254547119, 'What is 305,476,800 ?', 'shares']",shares,0.3006613254547119,"What is 305,476,800 ?",shares,2021 shares outstanding
12,"HCA Healthcare, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term ""affiliates"" includes direct and indirect subsidiaries of HCA Healthcare, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At March 31, 2022, these affiliates owned and operated 182 hospitals, 124 freestanding surgery centers, 21 freestanding endoscopy centers and provided extensive outpatient and ancillary services. HCA Healthcare, Inc.'s facilities are located in 20 states and England. The terms ""Company,"" ""HCA,"" ""we,"" ""our"" or ""us,"" as used herein and unless otherwise stated or indicated by context, refer to HCA Healthcare, Inc. and its affiliates. The terms ""facilities"" or ""hospitals"" refer to entities owned and operated by affiliates of HCA and the term ""employees"" refers to employees of affiliates of HCA.",182,['Number of owned and operated hospitals'],hca_NumberOfOwnedAndOperatedHospitals,integerItemType,hca,"At March 31, 2022, these affiliates owned and operated 182 hospitals, 124 freestanding surgery centers, 21 freestanding endoscopy centers and provided extensive outpatient and ancillary services.",182,CARDINAL,"At March 31, 2022, these affiliates owned and operated 182 hospitals, 124 freestanding surgery centers, 21 freestanding endoscopy centers and provided extensive outpatient and ancillary services.","['surgery centers', 'endoscopy centers', 'extensive outpatient']","['hospitals', 0.8651816248893738, 'What is 182 ?', 'hospitals']",hospitals,0.8651816248893738,What is 182 ?,hospitals,"Hospitals operated

Entity:
124
Phrase:
Freestanding surgery centers

Entity:
21
Phrase:
Freestanding endoscopy centers"
13,"Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10 Q and Article 10 of Regulation S X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature. The majority of our expenses are ""costs of revenues"" items. Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively. Operating results for the quarter are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10 K for the year ended December 31, 2021. COVID 19 On March 11, 2020, the World Health Organization designated COVID 19 as a global pandemic. We believe the extent of COVID 19's impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast. Because of these uncertainties, we cannot estimate how long or to what extent COVID 19 will impact our operations.",95,"['General and administrative expense', 'General and Administrative Expense, Total']",us-gaap_GeneralAndAdministrativeExpense,monetaryItemType,hca,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",$95 million,MONEY,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",['corporate office costs'],"['corporate office costs', 0.8461745381355286, 'What is $95 million ?', 'corporate office costs']",corporate office costs,0.8461745381355286,What is $95 million ?,corporate office costs,Quarterly general and administrative costs
14,"Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10 Q and Article 10 of Regulation S X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature. The majority of our expenses are ""costs of revenues"" items. Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively. Operating results for the quarter are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10 K for the year ended December 31, 2021. COVID 19 On March 11, 2020, the World Health Organization designated COVID 19 as a global pandemic. We believe the extent of COVID 19's impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast. Because of these uncertainties, we cannot estimate how long or to what extent COVID 19 will impact our operations.",87,"['General and administrative expense', 'General and Administrative Expense, Total']",us-gaap_GeneralAndAdministrativeExpense,monetaryItemType,hca,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",$87 million,MONEY,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",['corporate office costs'],"['corporate office costs', 0.15423135459423065, 'What is $87 million ?', 'corporate office costs']",corporate office costs,0.1542313545942306,What is $87 million ?,corporate office costs,General and administrative costs
15,"The majority of our expenses are ""costs of revenues"" items. Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively. Operating results for the quarter are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10 K for the year ended December 31, 2021.",95,"['General and administrative expense', 'General and Administrative Expense, Total']",us-gaap_GeneralAndAdministrativeExpense,monetaryItemType,hca,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",$95 million,MONEY,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",['corporate office costs'],"['corporate office costs', 0.8461745381355286, 'What is $95 million ?', 'corporate office costs']",corporate office costs,0.8461745381355286,What is $95 million ?,corporate office costs,Corporate office costs
16,"The majority of our expenses are ""costs of revenues"" items. Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively. Operating results for the quarter are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10 K for the year ended December 31, 2021.",87,"['General and administrative expense', 'General and Administrative Expense, Total']",us-gaap_GeneralAndAdministrativeExpense,monetaryItemType,hca,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",$87 million,MONEY,"Costs that could be classified as general and administrative would include our corporate office costs, which were $95 million and $87 million for the quarters ended March 31, 2022 and 2021, respectively.",['corporate office costs'],"['corporate office costs', 0.15423135459423065, 'What is $87 million ?', 'corporate office costs']",corporate office costs,0.1542313545942306,What is $87 million ?,corporate office costs,General and administrative costs
17,"Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third party payers. Estimates of contractual adjustments under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record these revenues at the estimated amounts we expect to collect. Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Our revenues by primary third party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions): 2022 Ratio 2021 Ratio Medicare $ 2,726 18.2 % $ 2,559 18.3 % Managed Medicare 2,324 15.6 2,053 14.7 Medicaid 579 3.9 527 3.8 Managed Medicaid 1,110 7.4 725 5.2 Managed care and insurers 7,152 47.9 6,885 49.1 International (managed care and insurers) 356 2.4 333 2.4 Other 698 4.6 895 6.5 Revenues $ 14,945 100.0 % $ 13,977 100.0 % Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services (""CMS"") approval of a Texas directed payment program for the current program year that began September 1, 2021. To quantify the total impact of the trends related to uninsured patient accounts, we believe it is beneficial to view total uncompensated care, which is comprised of charity care, uninsured discounts and implicit price concessions. A summary of the estimated cost of total uncompensated care for the quarters ended March 31, 2022 and 2021 follows (dollars in millions): 2022 2021 Patient care costs (salaries and benefits, supplies, other operating expense and depreciation and amortization) $ 12,744 $ 11,643 Cost to charges ratio (patient care costs as percentage of gross patient charges) 11.3 % 11.4 % Total uncompensated care $ 7,005 $ 6,821 Multiply by the cost to charges ratio 11.3 % 11.4 % Estimated cost of total uncompensated care $ 792 $ 778",400,['Percentage of income of federal poverty level eligible for charity care'],hca_PatientsTreatedAtHospitalsForNonelectiveCareIncomeLessThanOrEqualToSpecifiedPercentageOfFederalPovertyLevelEligibleForCharityCare,percentItemType,hca,"Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care.",below 400%,PERCENT,"Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care.","['% of federal poverty level', 'non elective care', 'federal poverty level', 'charity care']","['federal poverty level', 0.39290010929107666, 'What is below 400% ?', 'federal poverty level']",federal poverty level,0.3929001092910766,What is below 400% ?,federal poverty level,federal poverty level charity care
18,"Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third party payers. Estimates of contractual adjustments under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record these revenues at the estimated amounts we expect to collect. Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Our revenues by primary third party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions):",400,['Percentage of income of federal poverty level eligible for charity care'],hca_PatientsTreatedAtHospitalsForNonelectiveCareIncomeLessThanOrEqualToSpecifiedPercentageOfFederalPovertyLevelEligibleForCharityCare,percentItemType,hca,"Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care.",below 400%,PERCENT,"Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care.","['% of federal poverty level', 'non elective care', 'federal poverty level', 'charity care']","['federal poverty level', 0.39290010929107666, 'What is below 400% ?', 'federal poverty level']",federal poverty level,0.3929001092910766,What is below 400% ?,federal poverty level,federal poverty level
19,"Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third party payers. Estimates of contractual adjustments under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record these revenues at the estimated amounts we expect to collect. Patients treated at our hospitals for non elective care, who have income at or below 400% of the federal poverty level, are eligible for charity care. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Our revenues by primary third party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions): 2022 Ratio 2021 Ratio Medicare $ 2,726 18.2 % $ 2,559 18.3 % Managed Medicare 2,324 15.6 2,053 14.7 Medicaid 579 3.9 527 3.8 Managed Medicaid 1,110 7.4 725 5.2 Managed care and insurers 7,152 47.9 6,885 49.1 International (managed care and insurers) 356 2.4 333 2.4 Other 698 4.6 895 6.5 Revenues $ 14,945 100.0 % $ 13,977 100.0 % Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services (""CMS"") approval of a Texas directed payment program for the current program year that began September 1, 2021. To quantify the total impact of the trends related to uninsured patient accounts, we believe it is beneficial to view total uncompensated care, which is comprised of charity care, uninsured discounts and implicit price concessions. A summary of the estimated cost of total uncompensated care for the quarters ended March 31, 2022 and 2021 follows (dollars in millions): 2022 2021 Patient care costs (salaries and benefits, supplies, other operating expense and depreciation and amortization) $ 12,744 $ 11,643 Cost to charges ratio (patient care costs as percentage of gross patient charges) 11.3 % 11.4 % Total uncompensated care $ 7,005 $ 6,821 Multiply by the cost to charges ratio 11.3 % 11.4 % Estimated cost of total uncompensated care $ 792 $ 778",244,"['Revenues', 'Revenues, Total', 'Revenues from third party payers']",us-gaap_Revenues,monetaryItemType,hca,"Our revenues by primary third party payer classification and other (including uninsured patients) for the quarters ended March 31, 2022 and 2021 are summarized in the following table (dollars in millions):        2022     Ratio     2021     Ratio   Medicare   $ 2,726       18.2 %   $ 2,559       18.3 % Managed Medicare     2,324       15.6       2,053       14.7   Medicaid     579       3.9       527       3.8   Managed Medicaid     1,110       7.4       725       5.2   Managed care and insurers     7,152       47.9       6,885       49.1   International (managed care and insurers)     356       2.4       333       2.4   Other     698       4.6       895       6.5   Revenues   $ 14,945       100.0 %   $ 13,977       100.0 %  Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services (""CMS"") approval of a Texas directed payment program for the current program year that began September 1, 2021.",$244 million,MONEY,"Our revenues by primary third party payer classification and other  for the quarters ended March 31, 2022 and 2021 are summarized in the following table :        2022     Ratio     2021     Ratio   Medicare   $ 2,726       18.2 %   $ 2,559       18.3 % Managed Medicare     2,324       15.6       2,053       14.7   Medicaid     579       3.9       527       3.8   Managed Medicaid     1,110       7.4       725       5.2   Managed care and insurers     7,152       47.9       6,885       49.1   International      356       2.4       333       2.4   Other     698       4.6       895       6.5   Revenues   $ 14,945       100.0 %   $ 13,977       100.0 %  Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services  approval of a Texas directed payment program for the current program year that began September 1, 2021.","['revenues by primary payer other classification', 'revenues for quarters', '% Managed Medicaid revenues for quarter', 'period through December', 'Services approval of directed payment program', 'directed payment program for current program year', 'primary payer other classification', '% Managed Medicaid revenues', 'Services approval', 'payment program']","['', 0, '', '']",,0.0,,,Managed Medicaid revenues
20,"Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services (""CMS"") approval of a Texas directed payment program for the current program year that began September 1, 2021.",244,"['Revenues', 'Revenues, Total', 'Revenues from third party payers']",us-gaap_Revenues,monetaryItemType,hca,"Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services (""CMS"") approval of a Texas directed payment program for the current program year that began September 1, 2021.",$244 million,MONEY,"Managed Medicaid revenues for the quarter ended March 31, 2022 include $244 million, for the period September through December 2021, related to the March 2022 Centers for Medicare & Medicaid Services  approval of a Texas directed payment program for the current program year that began September 1, 2021.","['Managed Medicaid revenues for quarter', 'period through December', 'Services approval of directed payment program', 'directed payment program for current program year', 'Managed Medicaid revenues', 'Services approval', 'payment program']","['Managed Medicaid revenues for quarter', 0.9857129454612732, 'what is Managed Medicaid revenues for quarter ?', '$244 million']",Managed Medicaid revenues for quarter,0.9857129454612732,what is Managed Medicaid revenues for quarter ?,$244 million,Managed Medicaid revenues
21,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",3.458,['Charity care amount'],hca_CharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$3.458 billion,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['charity care', 0.9793950319290161, 'What is $3.458 billion ?', 'charity care']",charity care,0.979395031929016,What is $3.458 billion ?,charity care,"Charity care uncompensated care amounts

Entity: 
$2.942 billion
Phrase: 
Charity care uncompensated care amounts

Entity: 
$391 million
Phrase: 
Charity care uncompensated care estimated costs

Entity: 
$335 million
Phrase: 
Charity care uncompensated care estimated costs"
22,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",2.942,['Charity care amount'],hca_CharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$2.942 billion,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['charity care', 0.9577418565750122, 'What is $2.942 billion ?', 'charity care']",charity care,0.9577418565750122,What is $2.942 billion ?,charity care,Charity care related estimated costs
23,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",391,['Estimated costs of charity care'],hca_EstimatedCostOfCharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$391 million,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['related estimated costs of charity care', 0.6160231232643127, 'what is related estimated costs of charity care ?', '$391 million and $335 million']",related estimated costs of charity care,0.6160231232643127,what is related estimated costs of charity care ?,$391 million and $335 million,Charity care estimated costs
24,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",335,['Estimated costs of charity care'],hca_EstimatedCostOfCharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$335 million,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['related estimated costs of charity care', 0.6160231232643127, 'what is related estimated costs of charity care ?', '$391 million and $335 million']",related estimated costs of charity care,0.6160231232643127,what is related estimated costs of charity care ?,$391 million and $335 million,Charity care related estimated costs
25,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",3.458,['Charity care amount'],hca_CharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$3.458 billion,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['charity care', 0.9793950319290161, 'What is $3.458 billion ?', 'charity care']",charity care,0.979395031929016,What is $3.458 billion ?,charity care,"Charity care uncompensated care amounts

Entity: 
$2.942 billion
Phrase:
Charity care uncompensated care amounts

Entity: 
$391 million
Phrase: 
Estimated costs of charity care"
26,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",2.942,['Charity care amount'],hca_CharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$2.942 billion,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['charity care', 0.9577418565750122, 'What is $2.942 billion ?', 'charity care']",charity care,0.9577418565750122,What is $2.942 billion ?,charity care,"Charity care

Entity: 
$3.458 billion
Phrase: 
Charity care"
27,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",391,['Estimated costs of charity care'],hca_EstimatedCostOfCharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$391 million,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['related estimated costs of charity care', 0.6160231232643127, 'what is related estimated costs of charity care ?', '$391 million and $335 million']",related estimated costs of charity care,0.6160231232643127,what is related estimated costs of charity care ?,$391 million and $335 million,Charity care related estimated costs
28,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",335,['Estimated costs of charity care'],hca_EstimatedCostOfCharityCare,monetaryItemType,hca,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.",$335 million,MONEY,"The total uncompensated care amounts for the quarters ended March 31, 2022 and 2021 include charity care of $3.458 billion and $2.942 billion, respectively, and the related estimated costs of charity care were $391 million and $335 million, respectively.","['charity care', 'related estimated costs of charity care', 'total uncompensated care', 'charity care', 'related costs', 'charity care']","['related estimated costs of charity care', 0.6160231232643127, 'what is related estimated costs of charity care ?', '$391 million and $335 million']",related estimated costs of charity care,0.6160231232643127,what is related estimated costs of charity care ?,$391 million and $335 million,Charity care related estimated costs
29,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. 9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",2,['Aggregate purchase price'],us-gaap_PaymentsToAcquireBusinessesGross,monetaryItemType,hca,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",$2 million,MONEY,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",['nonhospital care entities'],"['to acquire nonhospital health care entities', 0.3701545298099518, 'What is $2 million ?', 'to acquire nonhospital health care entities']",to acquire nonhospital health care entities,0.3701545298099518,What is $2 million ?,to acquire nonhospital health care entities,Nonhospital health care entities
30,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. 9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",22,['Aggregate purchase price'],us-gaap_PaymentsToAcquireBusinessesGross,monetaryItemType,hca,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",$22 million,MONEY,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",['nonhospital care entities'],"['to acquire nonhospital health care entities', 0.5152788162231445, 'What is $22 million ?', 'to acquire nonhospital health care entities']",to acquire nonhospital health care entities,0.5152788162231445,What is $22 million ?,to acquire nonhospital health care entities,We paid to acquire nonhospital health care entities.
31,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values.",2,['Aggregate purchase price'],us-gaap_PaymentsToAcquireBusinessesGross,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",$2 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",['nonhospital care entities'],"['to acquire nonhospital health care entities', 0.37830376625061035, 'What is $2 million ?', 'to acquire nonhospital health care entities']",to acquire nonhospital health care entities,0.3783037662506103,What is $2 million ?,to acquire nonhospital health care entities,"Quarters ended March 31, 2022"
32,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values.",22,['Aggregate purchase price'],us-gaap_PaymentsToAcquireBusinessesGross,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",$22 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",['nonhospital care entities'],"['to acquire nonhospital health care entities', 0.41703537106513977, 'What is $22 million ?', 'to acquire nonhospital health care entities']",to acquire nonhospital health care entities,0.4170353710651397,What is $22 million ?,to acquire nonhospital health care entities,Nonhospital health care entities
33,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. 9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",14,"['Sales of hospitals and health care entities', 'Proceeds from sale of business']",us-gaap_ProceedsFromDivestitureOfBusinesses,monetaryItemType,hca,"9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$14 million and $20 million,MONEY,"9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  NOTE 2 — ACQUISITIONS AND DISPOSITIONS  During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['INC . NOTES TO STATEMENTS NOTE', 'proceeds', 'pretax gains', 'sales of real estate', 'STATEMENTS NOTE', 'pretax gains', 'real estate']","['proceeds', 0.9703039526939392, 'What is $14 million and $20 million ?', 'proceeds']",proceeds,0.9703039526939392,What is $14 million and $20 million ?,proceeds,Proceeds from sale of real estate
34,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. 9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",10,"['Pretax gain  before tax', 'Discontinued Operation, Gain  from Disposal of Discontinued Operation, before Income Tax, Total']",us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,monetaryItemType,hca,"9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$10 million and $2 million,MONEY,"9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  NOTE 2 — ACQUISITIONS AND DISPOSITIONS  During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['INC . NOTES TO STATEMENTS NOTE', 'proceeds', 'pretax gains', 'sales of real estate', 'STATEMENTS NOTE', 'pretax gains', 'real estate']","['pretax gains', 0.8074536323547363, 'What is $10 million and $2 million ?', 'pretax gains']",pretax gains,0.8074536323547363,What is $10 million and $2 million ?,pretax gains,real estate and other health care entity investments
35,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. 9 HCA HEALTHCARE, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued) NOTE 2 — ACQUISITIONS AND DISPOSITIONS (continued) During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",2,"['Pretax gain  before tax', 'Discontinued Operation, Gain  from Disposal of Discontinued Operation, before Income Tax, Total']",us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,monetaryItemType,hca,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",$2 million,MONEY,"NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the quarters ended March 31, 2022 and 2021, we paid $2 million and $22 million, respectively, to acquire nonhospital health care entities.",['nonhospital care entities'],"['to acquire nonhospital health care entities', 0.3701545298099518, 'What is $2 million ?', 'to acquire nonhospital health care entities']",to acquire nonhospital health care entities,0.3701545298099518,What is $2 million ?,to acquire nonhospital health care entities,nonhospital health care entities
36,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",14,"['Sales of hospitals and health care entities', 'Proceeds from sale of business']",us-gaap_ProceedsFromDivestitureOfBusinesses,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$14 million and $20 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['proceeds', 'pretax gains', 'sales of real estate', 'pretax gains', 'real estate']","['proceeds', 0.9834752678871155, 'What is $14 million and $20 million ?', 'proceeds']",proceeds,0.9834752678871156,What is $14 million and $20 million ?,proceeds,proceeds from sales of real estate and other health care entity investments
37,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",20,"['Sales of hospitals and health care entities', 'Proceeds from sale of business']",us-gaap_ProceedsFromDivestitureOfBusinesses,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$14 million and $20 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['proceeds', 'pretax gains', 'sales of real estate', 'pretax gains', 'real estate']","['proceeds', 0.9834752678871155, 'What is $14 million and $20 million ?', 'proceeds']",proceeds,0.9834752678871156,What is $14 million and $20 million ?,proceeds,proceeds from sales of real estate and other health care entity investments
38,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",10,"['Pretax gain  before tax', 'Discontinued Operation, Gain  from Disposal of Discontinued Operation, before Income Tax, Total']",us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$10 million and $2 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['proceeds', 'pretax gains', 'sales of real estate', 'pretax gains', 'real estate']","['pretax gains', 0.9128268957138062, 'What is $10 million and $2 million ?', 'pretax gains']",pretax gains,0.9128268957138062,What is $10 million and $2 million ?,pretax gains,real estate and other health care entity investments
39,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",2,"['Pretax gain  before tax', 'Discontinued Operation, Gain  from Disposal of Discontinued Operation, before Income Tax, Total']",us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax,monetaryItemType,hca,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.",$14 million and $20 million,MONEY,"During the quarters ended March 31, 2022 and 2021, we received proceeds of $14 million and $20 million, respectively, and recognized pretax gains of $10 million and $2 million, respectively, related to sales of real estate and other health care entity investments.","['proceeds', 'pretax gains', 'sales of real estate', 'pretax gains', 'real estate']","['proceeds', 0.9834752678871155, 'What is $14 million and $20 million ?', 'proceeds']",proceeds,0.9834752678871156,What is $14 million and $20 million ?,proceeds,Proceeds from sales of real estate and other health care entity investments.
40,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",349,"['Income Tax Expense , Total', 'Provision for income taxes']",us-gaap_IncomeTaxExpenseBenefit,monetaryItemType,hca,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",$349 million,MONEY,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['income taxes', 0.34960582852363586, 'what is income taxes ?', '$349 million and $393 million']",income taxes,0.3496058285236358,what is income taxes ?,$349 million and $393 million,"Income taxes for the quarter ended March 31, 2022"
41,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",393,"['Income Tax Expense , Total', 'Provision for income taxes']",us-gaap_IncomeTaxExpenseBenefit,monetaryItemType,hca,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",$393 million,MONEY,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['income taxes', 0.34960582852363586, 'what is income taxes ?', '$349 million and $393 million']",income taxes,0.3496058285236358,what is income taxes ?,$349 million and $393 million,"Income taxes for the quarter ended March 31, 2021"
42,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",21.5,['Effective tax rate'],us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,percentItemType,hca,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",21.5%,PERCENT,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['effective tax rates', 0.7800697088241577, 'What is 21.5% ?', 'effective tax rates']",effective tax rates,0.7800697088241577,What is 21.5% ?,effective tax rates,"Income tax provisions

Entity:
21.7%
Phrase:
Income tax provisions"
43,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",21.7,['Effective tax rate'],us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,percentItemType,hca,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",21.7%,PERCENT,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['effective tax rates', 0.7576622366905212, 'What is 21.7% ?', 'effective tax rates']",effective tax rates,0.7576622366905212,What is 21.7% ?,effective tax rates,Effective tax rate
44,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",64,['Provision for tax benefits related to settlement of employee awards'],us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense,monetaryItemType,hca,"Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",$64 million and $74 million,MONEY,"Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.","['provisions for income taxes', 'settlements of equity awards', 'equity awards', 'settlements for quarters', 'income taxes', 'tax benefits', 'equity awards']","['employee equity awards', 0.42673763632774353, 'What is $64 million and $74 million ?', 'employee equity awards']",employee equity awards,0.4267376363277435,What is $64 million and $74 million ?,employee equity awards,Employee equity award settlements
45,"NOTE 3 — INCOME TAXES Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively. Our liability for unrecognized tax benefits was $654 million, including accrued interest of $104 million, as of March 31, 2022 ($642 million and $99 million, respectively, as of December 31, 2021). Unrecognized tax benefits of $230 million ($217 million as of December 31, 2021) would affect the effective rate, if recognized.",74,['Provision for tax benefits related to settlement of employee awards'],us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense,monetaryItemType,hca,"Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",$64 million and $74 million,MONEY,"Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.","['provisions for income taxes', 'settlements of equity awards', 'equity awards', 'settlements for quarters', 'income taxes', 'tax benefits', 'equity awards']","['employee equity awards', 0.42673763632774353, 'What is $64 million and $74 million ?', 'employee equity awards']",employee equity awards,0.4267376363277435,What is $64 million and $74 million ?,employee equity awards,"provision for income taxes, employee equity awards"
46,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",349,"['Income Tax Expense , Total', 'Provision for income taxes']",us-gaap_IncomeTaxExpenseBenefit,monetaryItemType,hca,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",$349 million,MONEY,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['income taxes', 0.34247317910194397, 'what is income taxes ?', '$349 million and $393 million']",income taxes,0.3424731791019439,what is income taxes ?,$349 million and $393 million,"Provisions for income taxes

Entity: 
$393 million
Phrase: 
Effective tax rates"
47,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",393,"['Income Tax Expense , Total', 'Provision for income taxes']",us-gaap_IncomeTaxExpenseBenefit,monetaryItemType,hca,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",$393 million,MONEY,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['income taxes', 0.34247317910194397, 'what is income taxes ?', '$349 million and $393 million']",income taxes,0.3424731791019439,what is income taxes ?,$349 million and $393 million,Provision for income taxes
48,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",21.5,['Effective tax rate'],us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,percentItemType,hca,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",21.5%,PERCENT,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['effective tax rates', 0.6533846259117126, 'what is effective tax rates ?', '21.5% and 21.7%']",effective tax rates,0.6533846259117126,what is effective tax rates ?,21.5% and 21.7%,"Effective tax rate for the quarter ended March 31, 2022

Entity: 
21.7%
Phrase: 
Effective tax rate for the quarter ended March 31, 2021"
49,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively. Our provisions for income taxes included tax benefits related to settlements of employee equity awards of $64 million and $74 million for the quarters ended March 31, 2022 and 2021, respectively.",21.7,['Effective tax rate'],us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,percentItemType,hca,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.",21.7%,PERCENT,"Our provisions for income taxes for the quarters ended March 31, 2022 and 2021 were $349 million and $393 million, respectively, and the effective tax rates were 21.5% and 21.7%, respectively.","['provisions for income taxes', 'provisions for quarters', 'income taxes', 'effective tax rates']","['effective tax rates', 0.6533846259117126, 'what is effective tax rates ?', '21.5% and 21.7%']",effective tax rates,0.6533846259117126,what is effective tax rates ?,21.5% and 21.7%,Effective tax rate
